A leading group of pediatricians said in a statement published September 19 that codeine is not safe for children and should not be used to relieve pain or coughs. [1]
The guidance nearly mirrors a January 2016 Food and Drug Administration (FDA) warning that codeine should not be given to children and most teens.
A 4th case of a superbug that is resistant to antibiotics of last resort has been reported in a Connecticut toddler, and health officials are scrambling to figure out where else the superbugs might be lurking.
Scientists have created a new opioid compound that’s as effective at killing pain as morphine, but without the side effects. It could mean thousands fewer people becoming addicted to prescription pain medication in the future. But untold effects are questionable, as it is modified by man.
The finding represents a turning point in the way scientists have traditionally tried to handle opiate addiction and overdoses.
Two drug companies, Genentech and OSI Pharmaceuticals, have agreed to pay $67 million to settle a whistleblower lawsuit accusing them of misleading doctors about the effectiveness of a cancer drug called Tarceva. – By agreeing to the settlement, neither company admitted any guilt.
Federal prosecutors in San Francisco announced the settlement on June 6, 2016.
A drug shortage is plaguing emergency rooms in the U.S., and considering 45 out of 100 people visit one every year, this could affect millions of Americans.
A new study published in the journal Academic Emergency Medicine shows drug shortages in ERs across the nation increased by more than 400% between 2001 and 2014.
Last week was a busy one for the Food and Drug Administration (FDA), as the nation’s health watchdog began taking serious action to combat the rising opioid crisis.
Source: CDC
It has been a busy month, in general, for top health officials.
Drug Prices are as bloated as post-binge politicians in America. But in China, it seems that drug prices are being slashed where it hurts – in Big Pharma’s collective wallet. A state-led campaign to slash drug prices has targeted some of the biggest drug manufacturers in the world.
President Obama’s appointee just sailed through the approval process, and has been approved as the next FDA Commissioner. What does this mean now that Robert Califf, known for having financial ties with Gambro, Regeneron, Gilead, AstraZeneca, Roche and other companies, but who is also equally in equity positions in four medical companies? It means the FDA has officially been bought by Big Pharma.
Kenneth Frazier, a chief executive of Merck & Co. and chairman of the industry lobbying group Pharmaceutical Research and Manufacturers of America, wants you to know why drug prices have gotten so out of hand.
According to Frazier:
